SCOPUS 정보 검색 플랫폼

Blood

Volumn 99, Issue 7, 2002, Pages 2625-2626

Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac [2]

(2) Nardella, Francis A a LeFevre, Jane A a

a Scottsdale Rheumatology (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DICLOFENAC; ETODOLAC; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; MELOXICAM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PIROXICAM; ROFECOXIB; SULINDAC; TOLMETIN;

APOPTOSIS; B LYMPHOCYTE; CELL KILLING; CHRONIC LYMPHATIC LEUKEMIA; DOSE RESPONSE; DRUG MECHANISM; HUMAN; LETTER; LEUKEMIA CELL; LYMPHOCYTE COUNT; PRIORITY JOURNAL;

EID: 0036530036 PISSN: 00064971 EISSN: None Source Type: Journal
DOI: 10.1182/blood.V99.7.2625 Document Type: Letter

Times cited : (17)

References (5)

1
- 0003119370
- Chronic lymphocytic leukemia and related diseases
- Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. New York, NY: McGraw-Hill
- (1995) Williams Hematology. 5th ed. , pp. 1017-1039
- Kipps, T.J.¹

2
- 0034649696
- Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia
- (2000) N Engl J Med , vol.343 , pp. 1750-1757
- Rai, K.R.¹ Peterson, B.L.² Appelbaum, F.³

3
- 0022486909
- Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indoie-1-acetic acid): A potent antlinflammatory drug: Conformation and absolute configuration of Its active enantiomer
- (1986) J Med Chem , vol.29 , pp. 871-874
- Humber, L.G.¹ Demerson, C.A.² Swaminathan, P.³ Bird, P.H.⁴

4
- 0033594911
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 associated wfh with human gastrointestinal toxicity: A full in vitro analysis
- (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 7563-7568
- Warner, T.D.¹ Giuliano, F.² Vojnovic, I.³ Bukasa, A.⁴ Mitchell, J.⁵ Vane, J.⁶

5
- 0028207597
- Etodolac clinical pharmacokinetics
- (1994) Clin Pharmacokinet , vol.26 , pp. 259-274
- Brocks, D.R.¹ Jamali, F.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.